VT News

Samantha Bosco

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid inflation and weaker consumer spending.
  • Analysts warn investors to be cautious of multiple risky stocks facing headwinds, including MicroStrategy and GameStop for reliance on volatile assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid inflation and weaker consumer spending.
  • Analysts warn investors to be cautious of multiple risky stocks facing headwinds, including MicroStrategy and GameStop for reliance on volatile assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Samantha Bosco

Top Topics

Trending in U.S.

World

Sport